Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
Date
2020Author
Saip, Pinar
Ozgur, Emre
Sen, Fatma
Gezer, Ugur
Ferhatoglu, Ferhat
Metadata
Show full item recordAbstract
BACKGROUND: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC).
Collections
- Makale [92796]